Interpace Biosciences Interpace Commences $30M Rights Offering The company said the offering will help raise capital while allowing existing shareholders to maintain their proportional ownership in the company. Interpace Biosciences Q3 Revenues Rise 15 Percent The company attributed the revenue gains to higher reimbursement rates and greater clinical services volume for its thyroid cancer tests. Interpace Biosciences Q2 Revenues More Than Double The company attributed the higher revenues to increased reimbursement rates and greater clinical services volume for its cancer tests. Interpace Biosciences Q1 Revenues Up 8 Percent The company attributed the revenue increase to improved performance in its clinical services business and increased reimbursement rates for its cancer tests. Interpace Biosciences to Review Strategic Alternatives The company, which was recently delisted from the Nasdaq, began a reorganization earlier this year in order to cut $7.2 million in annual costs. Apr 1, 2021 Interpace Biosciences Q4 Revenues More Than Double Feb 17, 2021 Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring Feb 1, 2021 Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker Jan 20, 2021 Interpace Bio Q3 Revenues Rise 6 Percent Oct 20, 2020 Interpace Biosciences Q2 Revenues Decline 14 Percent Jun 26, 2020 Interpace Biosciences Q1 Revenues Rise 53 Percent Apr 23, 2020 Interpace Biosciences Q4 2019 Revenues Drop 29 Percent, Miss Analyst Predictions Jan 13, 2020 Interpace Biosciences to Sell $20M in Preferred Stock, Plans Reverse Stock Split Jan 6, 2020 Interpace Biosciences, University of North Carolina Launch Barrett's Esophagus Study Dec 20, 2019 Interpace Biosciences Expanding Beyond Dx, Cancer With Acquisition, Name Change Premium Nov 13, 2019 Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences Oct 25, 2019 Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace Oct 17, 2019 Interpace Diagnostics Closes $13M Financing Investment Sep 30, 2019 Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans Sep 16, 2019 Interpace Diagnostics, Genecast Biotechnology Ink Worldwide Research Services Agreement Aug 13, 2019 Interpace Diagnostics Q2 Revenues Climb 14 Percent Jul 31, 2019 Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan Jul 29, 2019 Interpace Diagnostics Thyroid Assays Covered In-Network by Blue Shield of California Jul 22, 2019 Interpace Diagnostics, SelectHealth Sign Coverage Agreement for Thyroid Cancer Tests Jul 18, 2019 Helomics Inks Separate Pacts With UPMC, Interpace Dx for AI-Driven Oncology Decision Making Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Polarized Science Confidence A new survey finds that confidence in science among US adults is increasingly polarized, the Associated Press says. Time to Sit Back and Relax NPR reports that the US National Institutes of Health has transferred the last of its eligible former research chimpanzees to a sanctuary. Omicron-Focused Vaccines The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant. Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more.